Shields CL - Search Results

1

High-dose Intravitreal Topotecan for Perifoveal Recurrence of Retinoblastoma.

Woods MM, Bansal R, Shields CL. Woods MM, et al. Among authors: shields cl. Ophthalmol Retina. 2024 Nov 16:S2468-6530(24)00481-0. doi: 10.1016/j.oret.2024.10.010. Online ahead of print. Ophthalmol Retina. 2024. PMID: 39556070 No abstract available.

2

A novel 3D printing method for a notched eye plaque "dummy" for uveal melanoma brachytherapy.

Mourtada F, Belko S, Monane R, Pugliese R, Komarnicky-Kocher L, Lally SE, Wang W, Shields CL, Emrich J. Mourtada F, et al. Among authors: shields cl. Brachytherapy. 2024 Nov 12:S1538-4721(24)00396-9. doi: 10.1016/j.brachy.2024.09.002. Online ahead of print. Brachytherapy. 2024. PMID: 39537436

3

A Computational Approach to Characterize the Protein S-Mer Tyrosine Kinase (PROS1-MERTK) Protein-Protein Interaction Dynamics.

Djulbegovic MB, Gonzalez DJT, Laratelli L, Antonietti M, Uversky VN, Shields CL, Karp CL. Djulbegovic MB, et al. Among authors: shields cl. Cell Biochem Biophys. 2024 Nov 13. doi: 10.1007/s12013-024-01582-5. Online ahead of print. Cell Biochem Biophys. 2024. PMID: 39535659

4

Intravitreal Melphalan for Vitreous Metastases from Cutaneous Melanoma.

Cain RE, Chou YB, Shields CL. Cain RE, et al. Among authors: shields cl. Ophthalmology. 2024 Nov 9:S0161-6420(24)00636-5. doi: 10.1016/j.ophtha.2024.10.015. Online ahead of print. Ophthalmology. 2024. PMID: 39530956 No abstract available.

5

The Association Between Medical Insurance, Access to Care, and Outcomes for Patients with Uveal Melanoma in the United States.

Marks VA, Williams BK Jr, Leapman MS, Shields CL. Marks VA, et al. Among authors: shields cl. Semin Ophthalmol. 2024 Nov 9:1-12. doi: 10.1080/08820538.2024.2426479. Online ahead of print. Semin Ophthalmol. 2024. PMID: 39520301

6

Failure to Thrive With Unilateral Proptosis and Xanthocoria in a Young Boy.

Medina RJ, Bansal R, Shields CL. Medina RJ, et al. Among authors: shields cl. J Pediatr Ophthalmol Strabismus. 2024 Oct 28:1. doi: 10.3928/01913913-20241001-03. Online ahead of print. J Pediatr Ophthalmol Strabismus. 2024. PMID: 39465577 No abstract available.

7

Artificial Intelligence and Machine Learning in Ocular Oncology, Retinoblastoma (ArMOR): Experience with a Multiracial Cohort.

Vempuluru VS, Viriyala R, Ayyagari V, Bakal K, Bhamidipati P, Dhara KK, Ferenczy SR, Shields CL, Kaliki S. Vempuluru VS, et al. Among authors: shields cl. Cancers (Basel). 2024 Oct 17;16(20):3516. doi: 10.3390/cancers16203516. Cancers (Basel). 2024. PMID: 39456609 Free PMC article.

8

Three vs 6 Cycles of Adjuvant Chemotherapy for Retinoblastoma.

Leahey AM, Shah A, Shields CL. Leahey AM, et al. Among authors: shields cl. JAMA Ophthalmol. 2024 Oct 21. doi: 10.1001/jamaophthalmol.2024.4859. Online ahead of print. JAMA Ophthalmol. 2024. PMID: 39432285 No abstract available.

9

Subconjunctival Mass 30 Years After Melanoma Resection.

Singh H, Kurian DE, Shields CL. Singh H, et al. Among authors: shields cl. JAMA Ophthalmol. 2024 Oct 17. doi: 10.1001/jamaophthalmol.2024.4289. Online ahead of print. JAMA Ophthalmol. 2024. PMID: 39418055

10

High-Dose Intravitreal Topotecan for Recurrent Retinoblastoma, Subretinal Seeds, and Vitreous Seeds in 13 Consecutive Cases.

Shields CL, Medina R, Evans H, Valdes-Perez N, Burak A, Bansal R, Lally SE, Shields JA. Shields CL, et al. Retina. 2024 Oct 1. doi: 10.1097/IAE.0000000000004283. Online ahead of print. Retina. 2024. PMID: 39378373

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,562 results

Search Page

Filters